---
schema_version: "secwatch.filing_event.v1"
accession: "0001787400-26-000005"
form_type: "8-K"
ticker: "NKTX"
cik: "0001787400"
company_name: "Nkarta, Inc."
filed_at: "2026-03-25T23:59:59+00:00"
generated_at: "2026-05-15T09:02:53.463127+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nkarta reports FY2025 net loss of $104.1M; cash runway into 2029

## Summary
- Cash, equivalents and investments $295.1M at Dec 31, 2025; expected to fund operations into 2029.
- Full-year net loss $104.1M ($1.41 per share); Q4 net loss $27.4M ($0.37 per share).
- NKX019 dose escalation advanced to 4 billion cells per dose in Ntrust-1 and Ntrust-2 trials.
- Initial clinical data from Ntrust-1 and Ntrust-2 planned for presentation at a medical conference in 2026.

## SEC filing metadata
- accession: 0001787400-26-000005
- form_type: 8-K
- ticker: NKTX
- cik: 0001787400
- company_name: Nkarta, Inc.
- filed_at: 2026-03-25T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787400/000178740026000005/0001787400-26-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787400/000178740026000005/nktx-20260325.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001787400-26-000005
- JSON: https://secwatch.observer/filing/0001787400-26-000005.json
- Plain text: https://secwatch.observer/filing/0001787400-26-000005.txt

## Key facts
- Earnings Releases
  Nkarta, Inc. reported the fourth quarter and year ended December 31, 2025 results: net income Net loss was $104.1 million, or $1.41 per basic and diluted share, for the full year 2025. Net loss was $27.4 million, o, EPS $1.41 per basic and diluted share (full year); $0.37 per basic and diluted share (fourth quarter).
  - Period: the fourth quarter and year ended December 31, 2025
  - Net income: Net loss was $104.1 million, or $1.41 per basic and diluted share, for the full year 2025. Net loss was $27.4 million, o
  - EPS: $1.41 per basic and diluted share (full year); $0.37 per basic and diluted share (fourth quarter)
  - Result: reported results
  source text: On March 25, 2026, Nkarta, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787400/000178740026000005/0001787400-26-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.